Elis Pharmaceuticals

Focuses its resources in pursuing development and marketing proprietary medicines. The company manufactures and markets various Generic drugs and Nutraceutical formulations globally in different dosage forms. Elis showcase their breakthrough products namely Kids Chewable capsules (O-chewie SMART, MAX and STAR), Clarastill eyedrop solution, Can-C Plus capsule, Paracetamol infusion, Prussian Blue anti-radiation drug and Nutraceutical Products.

Monday, September 17, 2012

Apricus Biosciences' Wholly-Owned Subsidiary NexMed (U.S.A.) and Takeda Pharmaceuticals International GmbH Sign Exclusive License Agreement to Market Vitaros(R) in the United Kingdom (Nasdaq:APRI)

Apricus Biosciences' Wholly-Owned Subsidiary NexMed (U.S.A.) and Takeda Pharmaceuticals International GmbH Sign Exclusive License Agreement to Market Vitaros(R) in the United Kingdom (Nasdaq:APRI)
Posted by Elis Pharmaceuticals at 1:55 AM No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Newer Posts Older Posts Home
Subscribe to: Posts (Atom)

Followers

Blog Archive

  • ▼  2012 (1)
    • ▼  September (1)
      • Apricus Biosciences' Wholly-Owned Subsidiary NexMe...
  • ►  2011 (3)
    • ►  January (3)

About Me

My photo
Elis Pharmaceuticals
View my complete profile
Simple theme. Powered by Blogger.